These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

233 related items for PubMed ID: 27599268

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Evidence for induction of humoral and cytotoxic immune responses against devil facial tumor disease cells in Tasmanian devils (Sarcophilus harrisii) immunized with killed cell preparations.
    Kreiss A, Brown GK, Tovar C, Lyons AB, Woods GM.
    Vaccine; 2015 Jun 12; 33(26):3016-25. PubMed ID: 25708088
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Demonstration of immune responses against devil facial tumour disease in wild Tasmanian devils.
    Pye R, Hamede R, Siddle HV, Caldwell A, Knowles GW, Swift K, Kreiss A, Jones ME, Lyons AB, Woods GM.
    Biol Lett; 2016 Oct 12; 12(10):. PubMed ID: 28120799
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Extracellular vesicle proteomes of two transmissible cancers of Tasmanian devils reveal tenascin-C as a serum-based differential diagnostic biomarker.
    Espejo C, Wilson R, Willms E, Ruiz-Aravena M, Pye RJ, Jones ME, Hill AF, Woods GM, Lyons AB.
    Cell Mol Life Sci; 2021 Dec 12; 78(23):7537-7555. PubMed ID: 34655299
    [Abstract] [Full Text] [Related]

  • 7. Immunoglubolin dynamics and cancer prevalence in Tasmanian devils (Sarcophilus harrisii).
    Ujvari B, Hamede R, Peck S, Pemberton D, Jones M, Belov K, Madsen T.
    Sci Rep; 2016 Apr 29; 6():25093. PubMed ID: 27126067
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Doxorubicin and carboplatin trials in Tasmanian devils (Sarcophilus harrisii) with Tasmanian devil facial tumor disease.
    Phalen DN, Frimberger AE, Peck S, Pyecroft S, Harmsen C, Lola S, Moore AS.
    Vet J; 2015 Dec 29; 206(3):312-6. PubMed ID: 26538144
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Season, weight, and age, but not transmissible cancer, affect tick loads in the endangered Tasmanian devil.
    Belkhir S, Hamede R, Thomas F, Ujvari B, Dujon AM.
    Infect Genet Evol; 2022 Mar 29; 98():105221. PubMed ID: 35065301
    [Abstract] [Full Text] [Related]

  • 16. Mitogen-activated Tasmanian devil blood mononuclear cells kill devil facial tumour disease cells.
    Brown GK, Tovar C, Cooray AA, Kreiss A, Darby J, Murphy JM, Corcoran LM, Bettiol SS, Lyons AB, Woods GM.
    Immunol Cell Biol; 2016 Aug 29; 94(7):673-9. PubMed ID: 27089941
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.